Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept

Ítems similars

• Radiographic efficacy of adalimumab in patients with psoriatic arthritis according to demographics, baseline clinical status, methotrexate use and clinical response: subanalysis of adept
  per: Choy, E, et al.
  Publicat: (2007)
• Effectiveness and safety of adalimumab in treating moderate to severe psoriasis patients with psoriatic arthritis in Taiwan
  per: Pei-Han Kao, et al.
  Publicat: (2015-09-01)
• Adalimumab in treatment of psoriatic arthritis
  per: V. V. Badokin
  Publicat: (2008-08-01)
• Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial
  per: Mease, P, et al.
  Publicat: (2017)
• Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity
  per: Landewé, R, et al.
  Publicat: (2019)